Correlation Between METALL ZUG and Faron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both METALL ZUG and Faron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining METALL ZUG and Faron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between METALL ZUG AG and Faron Pharmaceuticals Oy, you can compare the effects of market volatilities on METALL ZUG and Faron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in METALL ZUG with a short position of Faron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of METALL ZUG and Faron Pharmaceuticals.

Diversification Opportunities for METALL ZUG and Faron Pharmaceuticals

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between METALL and Faron is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding METALL ZUG AG and Faron Pharmaceuticals Oy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Faron Pharmaceuticals and METALL ZUG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on METALL ZUG AG are associated (or correlated) with Faron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Faron Pharmaceuticals has no effect on the direction of METALL ZUG i.e., METALL ZUG and Faron Pharmaceuticals go up and down completely randomly.

Pair Corralation between METALL ZUG and Faron Pharmaceuticals

Assuming the 90 days trading horizon METALL ZUG AG is expected to generate 0.25 times more return on investment than Faron Pharmaceuticals. However, METALL ZUG AG is 4.05 times less risky than Faron Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Faron Pharmaceuticals Oy is currently generating about -0.09 per unit of risk. If you would invest  120,500  in METALL ZUG AG on September 23, 2024 and sell it today you would lose (6,000) from holding METALL ZUG AG or give up 4.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

METALL ZUG AG  vs.  Faron Pharmaceuticals Oy

 Performance 
       Timeline  
METALL ZUG AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days METALL ZUG AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, METALL ZUG is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Faron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

METALL ZUG and Faron Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with METALL ZUG and Faron Pharmaceuticals

The main advantage of trading using opposite METALL ZUG and Faron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if METALL ZUG position performs unexpectedly, Faron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Faron Pharmaceuticals will offset losses from the drop in Faron Pharmaceuticals' long position.
The idea behind METALL ZUG AG and Faron Pharmaceuticals Oy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies